TY - JOUR
T1 - Cellular immune activity biomarker neopterin is associated hyperlipidemia
T2 - Results from a large population-based study
AU - Chuang, Shu Chun
AU - Boeing, Heiner
AU - Vollset, Stein Emil
AU - Midttun, Øivind
AU - Ueland, Per Magne
AU - Bueno-de-Mesquita, Bas
AU - Lajous, Martin
AU - Fagherazzi, Guy
AU - Boutron-Ruault, Marie Christine
AU - Kaaks, Rudolf
AU - Küehn, Tilman
AU - Pischon, Tobias
AU - Drogan, Dagmar
AU - Tjønneland, Anne
AU - Overvad, Kim
AU - Quirós, J. Ramón
AU - Agudo, Antonio
AU - Molina-Montes, Esther
AU - Dorronsoro, Miren
AU - Huerta, José María
AU - Barricarte, Aurelio
AU - Khaw, Kay Tee
AU - Wareham, Nicholas J.
AU - Travis, Ruth C.
AU - Trichopoulou, Antonia
AU - Lagiou, Pagona
AU - Trichopoulos, Dimitrios
AU - Masala, Giovanna
AU - Agnoli, Claudia
AU - Tumino, Rosario
AU - Mattiello, Amalia
AU - Peeters, Petra H.
AU - Weiderpass, Elisabete
AU - Palmqvist, Richard
AU - Ljuslinder, Ingrid
AU - Gunter, Marc
AU - Lu, Yunxia
AU - Cross, Amanda J.
AU - Riboli, Elio
AU - Vineis, Paolo
AU - Aleksandrova, Krasimira
N1 - Publisher Copyright:
© 2016 Chuang et al.
PY - 2016/2/25
Y1 - 2016/2/25
N2 - Background: Increased serum neopterin had been described in older age two decades ago. Neopterin is a biomarker of systemic adaptive immune activation that could be potentially implicated in metabolic syndrome (MetS). Measurements of waist circumference, triglycerides, high-density lipoprotein cholesterol (HDLC), systolic and diastolic blood pressure, glycated hemoglobin as components of MetS definition, and plasma total neopterin concentrations were performed in 594 participants recruited in the European Prospective Investigation into Cancer and Nutrition (EPIC). Results: Higher total neopterin concentrations were associated with reduced HDLC (9.7 %, p < 0.01 for men and 9.2 %, p < 0.01 for women), whereas no association was observed with the rest of the MetS components as well as with MetS overall (per 10 nmol/L: OR = 1.42, 95 % CI = 0.85-2.39 for men and OR = 1.38, 95 % CI = 0.79-2.43). Conclusions: These data suggest that high total neopterin concentrations are cross-sectionally associated with reduced HDLC, but not with overall MetS.
AB - Background: Increased serum neopterin had been described in older age two decades ago. Neopterin is a biomarker of systemic adaptive immune activation that could be potentially implicated in metabolic syndrome (MetS). Measurements of waist circumference, triglycerides, high-density lipoprotein cholesterol (HDLC), systolic and diastolic blood pressure, glycated hemoglobin as components of MetS definition, and plasma total neopterin concentrations were performed in 594 participants recruited in the European Prospective Investigation into Cancer and Nutrition (EPIC). Results: Higher total neopterin concentrations were associated with reduced HDLC (9.7 %, p < 0.01 for men and 9.2 %, p < 0.01 for women), whereas no association was observed with the rest of the MetS components as well as with MetS overall (per 10 nmol/L: OR = 1.42, 95 % CI = 0.85-2.39 for men and OR = 1.38, 95 % CI = 0.79-2.43). Conclusions: These data suggest that high total neopterin concentrations are cross-sectionally associated with reduced HDLC, but not with overall MetS.
KW - Cell-mediated immunity
KW - Metabolic syndrome
KW - Neopterin
UR - http://www.scopus.com/inward/record.url?scp=84975682924&partnerID=8YFLogxK
U2 - 10.1186/s12979-016-0059-y
DO - 10.1186/s12979-016-0059-y
M3 - Article
AN - SCOPUS:84975682924
SN - 1742-4933
VL - 13
JO - Immunity and Ageing
JF - Immunity and Ageing
IS - 1
M1 - 5
ER -